Immunologic Markers of Clinical Evolution in Children Recently Infected with Leishmania donovani chagasi

Journal of Infectious Diseases

Volumn 165, Issue 3, 1992, Pages 535-540

  Carvalho, Edgar M ^a,b   Barral, Aldina ^a,b   Pedral Sampaio, Diana ^a,b   Barral Netto, Manoel ^a,b   Badaro, Roberto ^a,b   Rocha, Heonir ^a,b   Johnson, Warren D ^a,b  

^a Servifo de Imunologia ^*  (Brazil)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON;

ADOLESCENT; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; FEMALE; HUMAN; IMMUNE RESPONSE; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; VISCERAL LEISHMANIASIS;

ADOLESCENT; ANIMAL; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNE SERA; IMMUNITY, CELLULAR; INFANT; INTERFERON TYPE II; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 0026585442     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/165.3.535     Document Type: Article

References (30)

1. Badaró R, Jones TC, Carvalho EM, et al. New perspectives on a sub-clinical form of visceral leishmaniasis. J Infect Dis 1986; 1 54:1003-11.
2. Carvalho EM, Badaró R, Reed SG, Jones TC, Johnson WD. Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 1985;76:2066-70.
3. Sacks DI., Lata LS, Shrivastarea SN, Blackwell J, Neva FA. An analysis of T cells responsiveness in Indian kala-azar. J Immunol 1987;138:908-13.
4. Carvalho EM. Teixeira R, Johnson WD. Cell mediated immunity in American visceral leishmaniasis: reversible immune suppression during acute infection. Infect Immun 1981;33:498-502.
5. Carvalho EM, Bacellar O, Reed S, Barrai A, Rocha H. Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania. Braz J Med Biol Res 1988;21:85-92.
6. Rezai JR, Ardehali SM, Amirhakimi G, Kharazmi A. Immunological features of kala-azar. Am J Trop Med Hyg 1978;27:1079-83.
7. Musumeci S, Schilino G, Li Volti S, Sciotto A. Lymphocyte changes in Mediterranean kala-azar. Trans R Soc Trop Med Hyg 1980;75:304-5.
8. Carvalho EM, Bacellar O, Barrai A, Badaró R, Johnson WD Jr. Antigen specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 1989;83:860-4.
9. Carvalho EM, Bacellar O. Lymphocyte reactivity to mitogens in American visceral leishmaniasis. Braz J Med Biol Res 1983;16:35-41.
10. Barrai A, Carvalho EM, Badaró R. Barral-Netto M. Suppression of lymphocyte proliferative response by sera from patients with American visceral leishmaniasis. Am J Trop Med Hyg 1986;35:735-42.
11. Ma DDF, Concannon AJ, Hayes J. Fatal leishmaniasis in a renal transplant patient. Lancet 1979;2:31 1-2.
12. Badaro R, Carvalho EM. Rocha H, Queiroz C, Jones TC. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1986;1:746-8.
13. Fernandez-Guerreiro ML, Agnaldo JM, Buzon L, et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987;83:1098-2.
14. Badaro R, Jones TC, Lorenzo R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986;154:639-49.
15. Horwitz DA, Garret MA. Distinctive functional properties of human blood lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes. J Immunol 1987; 118:1712-21.
16. Chang TW, McKinney S, Lin V, Kung PC, Vilkek J, Le J. Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma interferon. Proc Nall Acad Sci USA 1984;81:5219-22.
17. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 1979;6:4061-5.
18. Reed SG, Badaro R, Masur H, et al. Selection of a specific skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 1986;35:77-85.
19. Lowry DH, Rosembrongh NG, Farr AL, Randall RG. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
20. Badaro R, Reed SG, Barral A, Orge MG, Jones TC. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies to American visceral leishmaniasis: standardization of parasite antigen to detect infection specific response. Am J Trop Med Hyg 1986;35:72-8.
21. Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, Johnson WD Jr. Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 1987;156:1030-5.
22. Murray HW. Masur H, Keithly JS. Cell mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to L. donovani and lymphokine generation capacity. J Immunol 1982;131:1487-91.
23. Sadick MD, Loksley RM, Tibbs C, Raff HV. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to leishmania antigens in vitro. J Immunol 1986;136:655-61.
24. Scott P, Pearce E, Matovitz P, Sher A. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunological properties of protective and non-protective subpopulations of a soluble promastigotes extract. J Immunol 1987; 139:31 18-25.
25. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675-83.
26. Reiner NE, Ng W, Wilson CB, Mamaster WR, Burchett SR. Modulation of in vitro monocyte cytokine responses to L. donovani interferon-gamma prevents parasite-induced inhibition of IL-1 production and primes monocytes to respond to leishmania by producing both tumor necrosis factor alpha and IL-1. J Clin Invest 1990;85:1914-24.
27. Reiner NE, Ng W, Ma T, Mamaster WR. Kinetics of IFN-γ binding and MHC' class I in RNA levels in leishmania-infected macrophages. Proc Natl Acad Sci 1988;85:4330-4.
28. Huiid L, Soreneen AL, Kharazmi A, Theander TG. Functional and phenotypic changes in human lymphocytes after coincubation with L. donovani in vitro. Infect Immun 1990;56:3163-7.
29. Koech DK. Subpopulations of T lymphocytes, in Kenyan patients with visceral leishmaniasis. Am J Trop Med Hyg 1987;36:497-500.
30. Badaro R, Carvalho EM, Orge MG, Teixeira RS, Rocha H. Imunidade humoral e celular em individuos curados de leishmania visceral. Rev Soc Braz Med Trop 1985;18:77-83.